Dentons and Latham & Watkins advised ATAI Life Sciences on the deal. ATAI Life Sciences closed a $125 million Series C financing round. Founding investor Apeiron…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now